Tahlil

Kronik Lösemi Paneli (KLL)

Sanal Hastane||1 dk okuma
Kronik Lösemi Paneli (KLL)


Kronik lenfositik lösemi (KLL) tüm lösemilerin yaklaşık %30’unu

oluşturur. Yetişkinlerdeki en yaygın nedenidir. Tanısının konulduğu

ortalama yaş 64’dür. KLL, B-lenfositlerin klonal bozukluğudur.

KLL alt grupları ve diğer lösemi çeşitleri;

B-KLL (tipik) % 90-95

Diğerleri % 1-5

*Prolenfositik lösemi,

*Malign lenfoma, lösemi,

*Geniş granüler lenfositik lösemi,

*Yetişkin T hücreli lenfoması/lösemisi,

*Mycozis fungoides/ Sezary sendromu,

*Plazma hücreli lösemi,

*Hairy cell lösemi.

#Geniş granüler lenfositik lösemi#Hairy cell lösemi#KLL#Kronik lenfositik lösemi#Lösemi#Malign lenfoma#Mycozis fungoides/ Sezary sendromu#Plazma hücreli lösemi#Prolenfositik lösemi#Yetişkin T hücreli lenfoması/lösemisi

Kaynaklar ve Referanslar

  1. [1]Knisbacher BA, Lin Z, Hahn CK, et al. “Molecular map of chronic lymphocytic leukemia and its impact on outcome.”. Nature genetics. 2022. PMID: 35927489. PubMed →
  2. [2]Parikh SA, Hampel PJ, Roeker LE, et al.. “Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026.”. Mayo Clin Proc. 2026. PMID: 42246910. PubMed →
  3. [3]Hallek M, Cheson BD, Catovsky D, et al. “iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.”. Blood. 2018. PMID: 29540348. PubMed →
  4. [4]Adrados A, Pérez-Fernández J, García-Vicente R, et al.. “Enhancing immunotherapy efficacy in multiple myeloma and chronic lymphocytic leukemia: from combinatorial therapeutic approaches to gut microbiota modulation.”. Front Immunol. 2026. PMID: 42389542. PubMed →
  5. [5]Parry EM, Leshchiner I, Guièze R, et al. “Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.”. Nature medicine. 2023. PMID: 36624313. PubMed →
  6. [6]Medina A, Muntañola A, Crespo M, et al.. “Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)”. Medicina Clinica (Barc). 2025. PMID: 39799061. PubMed →
Paylaş:
← Tüm Makaleler